Based on whole-genome sequencing (WGS), the investigational test detected circulating tumor (ct)DNA with a sensitivity and ...

A new, rapid testing method will greatly help the diagnosis of rare diseases in babies and children, according to research ...

Developed by the company’s researchers, the blood test utilises shallow whole-genome sequencing of cell-free DNA.

A new rapid blood test for newborns could potentially detect genetic mutations linked to thousands of rare diseases all at ...

In a proof-of-concept study, the test successfully identified five critical biomarkers associated with Alzheimer’s disease, exceeding the capabilities of currently available commercial blood tests. Re ...

An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient’s blood, ...

An AI-based blood test devised by Johns Hopkins Kimmel Cancer Center has been proven to speed up pancreatic cancer treatment.

Collectively, the data presented here suggest that the PhasED-Seq-based MRD assay is accurate and reproducible, making it appropriate for use in the ...

The FDA cleared marketing for the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer disease.